|
1
|
Levin SN and Lyons JL: HIV and spinal cord
disease. Handb Clin Neurol. 152:213–227. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Ahuja CS, Wilson JR, Nori S, Kotter MRN,
Druschel C, Curt A and Fehlings MG: Traumatic spinal cord injury.
Nat Rev Dis Primers. 3(17018)2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Orr MB and Gensel JC: Interactions of
primary insult biomechanics and secondary cascades in spinal cord
injury: Implications for therapy. Neural Regen Res. 12:1618–1619.
2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Shao A, Tu S, Lu J and Zhang J: Crosstalk
between stem cell and spinal cord injury: Pathophysiology and
treatment strategies. Stem Cell Res Ther. 10(238)2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Sandrow-Feinberg HR and Houlé JD: Exercise
after spinal cord injury as an agent for neuroprotection,
regeneration and rehabilitation. Brain Res. 1619:12–21.
2015.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Zhaohui C and Shuihua W: Protective
effects of SIRT6 against inflammation, oxidative stress, and cell
apoptosis in spinal cord injury. Inflammation. 43:1751–1758.
2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Ji J, Lin W, Vrudhula A, Xi J, Yeliseev A,
Grothusen JR, Bu W and Liu R: Molecular interaction between
butorphanol and κ-opioid receptor. Anesth Analg. 131:935–942.
2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Wu Y, Wan J, Zhen WZ, Chen LF, Zhan J, Ke
JJ, Zhang ZZ and Wang YL: The effect of butorphanol
postconditioning on myocardial ischaemia reperfusion injury in
rats. Interact Cardiovasc Thorac Surg. 18:308–312. 2014.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Huang LH, Li J, Gu JP, Qu MX, Yu J and
Wang ZY: Butorphanol attenuates myocardial ischemia reperfusion
injury through inhibiting mitochondria-mediated apoptosis in mice.
Eur Rev Med Pharmacol Sci. 22:1819–1824. 2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Wang H, Wang JL, Ren HW, He WF and Sun M:
Butorphanol protects on myocardial ischemia/reperfusion injury in
rats through MAPK signaling pathway. Eur Rev Med Pharmacol Sci.
23:10541–10548. 2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Tang W, Luo L, Hu B and Zheng M:
Butorphanol alleviates lipopolysaccharide-induced inflammation and
apoptosis of cardiomyocytes via activation of the κ-opioid
receptor. Exp Ther Med. 22(1248)2021.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Vachon P and Moreau JP: Butorphanol
decreases edema following carrageenan-induced paw inflammation in
rats. Contemp Top Lab Anim Sci. 41:15–17. 2002.PubMed/NCBI
|
|
13
|
Meng J, Jiang SJ, Jiang D and Zhao Y:
Butorphanol attenuates inflammation via targeting NF-κB in septic
rats with brain injury. Eur Rev Med Pharmacol Sci. 23 (3
Suppl):S161–S170. 2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Yang Z, Wang L, Hu Y and Wang F:
Butorphanol protects PC12 cells against OGD/R-induced inflammation
and apoptosis. Mol Med Rep. 22:1969–1975. 2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Zhao P, Chao W and Li W: FBXW5 reduction
alleviates spinal cord injury (SCI) by blocking microglia activity:
A mechanism involving p38 and JNK. Biochem Biophys Res Commun.
514:558–564. 2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Geng W and Liu L: MiR-494 alleviates
lipopolysaccharide (LPS)-induced autophagy and apoptosis in PC-12
cells by targeting IL-13. Adv Clin Exp Med. 28:85–94.
2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Zhang HW, Ding JD, Zhang ZS, Zhao SS, Duan
KY, Zhu BQ, Zhao WF, Chai ZT and Liu XW: Critical Role of p38 in
spinal cord injury by regulating inflammation and apoptosis in a
rat model. Spine (Phila Pa 1976). 45:E355–E363. 2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Gao L, Xu W, Fan S, Li T, Zhao T, Ying G,
Zheng J, Li J, Zhang Z, Yan F, et al: MANF attenuates neuronal
apoptosis and promotes behavioral recovery via Akt/MDM-2/p53
pathway after traumatic spinal cord injury in rats. Biofactors.
2018.PubMed/NCBI View Article : Google Scholar : (Epub ahead of
print).
|
|
19
|
Fan H, Zhang K, Shan L, Kuang F, Chen K,
Zhu K, Ma H, Ju G and Wang YZ: Reactive astrocytes undergo M1
microglia/macrohpages-induced necroptosis in spinal cord injury.
Mol Neurodegener. 11(14)2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Tian JS, Liu SB, He XY, Xiang H, Chen JL,
Gao Y, Zhou YZ and Qin XM: Metabolomics studies on
corticosterone-induced PC12 cells: A strategy for evaluating an in
vitro depression model and revealing the metabolic regulation
mechanism. Neurotoxicol Teratol. 69:27–38. 2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Katsetos CD, Herman MM, Balin BJ, Vinores
SA, Hessler RB, Arking EJ, Karkavelas G and Frankfurter A: Class
III beta-tubulin isotype (beta III) in the adrenal medulla: III.
Differential expression of neuronal and glial antigens identifies
two distinct populations of neuronal and glial-like (sustentacular)
cells in the PC12 rat pheochromocytoma cell line maintained in a
Gelfoam matrix system. Anat Rec. 250:351–365. 1998.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Lu S, Luo Y, Zhou P, Yang K, Sun G and Sun
X: Ginsenoside compound K protects human umbilical vein endothelial
cells against oxidized low-density lipoprotein-induced injury via
inhibition of nuclear factor-κB, p38, and JNK MAPK pathways. J
Ginseng Res. 43:95–104. 2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Ma Z, Lu Y, Yang F, Li S, He X, Gao Y,
Zhang G, Ren E, Wang Y and Kang X: Rosmarinic acid exerts a
neuroprotective effect on spinal cord injury by suppressing
oxidative stress and inflammation via modulating the Nrf2/HO-1 and
TLR4/NF-κB pathways. Toxicol Appl Pharmacol.
397(115014)2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Hearn JH and Cross A: Mindfulness for
pain, depression, anxiety, and quality of life in people with
spinal cord injury: A systematic review. BMC Neurol.
20(32)2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Ambrozaitis KV, Kontautas E, Spakauskas B
and Vaitkaitis D: Pathophysiology of acute spinal cord injury.
Medicina (Kaunas). 42:255–261. 2006.PubMed/NCBI(In Lithuania).
|
|
27
|
Mourelo Fariña M, Salvador de la Barrera
S, Montoto Marqués A, Ferreiro Velasco ME and Galeiras Vázquez R:
Update on traumatic acute spinal cord injury. Part 2. Med
Intensiva. 41:306–315. 2017.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Galeiras Vázquez R, Ferreiro Velasco ME,
Mourelo Fariña M, Montoto Marqués A and Salvador de la Barrera S:
Update on traumatic acute spinal cord injury. Part 1. Med
Intensiva. 41:237–247. 2017.PubMed/NCBI View Article : Google Scholar : (In English,
Spanish).
|
|
29
|
Witiw CD and Fehlings MG: Acute spinal
cord injury. J Spinal Disord Tech. 28:202–210. 2015.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Rouanet C, Reges D, Rocha E, Gagliardi V
and Silva GS: Traumatic spinal cord injury: Current concepts and
treatment update. Arq Neuropsiquiatr. 75:387–393. 2017.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Cofano F, Boido M, Monticelli M, Zenga F,
Ducati A, Vercelli A and Garbossa D: Mesenchymal stem cells for
spinal cord injury: Current options, limitations, and future of
cell therapy. Int J Mol Sci. 20(2698)2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Ahuja CS, Nori S, Tetreault L, Wilson J,
Kwon B, Harrop J, Choi D and Fehlings MG: Traumatic Spinal Cord
Injury-Repair and Regeneration. Neurosurgery. 80:S9–S22.
2017.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Tang H, Guo Y, Zhao Y, Wang S, Wang J, Li
W, Qin S, Gong Y, Fan W, Chen Z, et al: Effects and mechanisms of
acupuncture combined with mesenchymal stem cell transplantation on
neural recovery after spinal cord injury: Progress and prospects.
Neural Plast. 2020(8890655)2020.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Orr MB and Gensel JC: Spinal cord injury
scarring and inflammation: Therapies targeting glial and
inflammatory responses. Neurotherapeutics. 15:541–553.
2018.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Tyor WR, Avgeropoulos N, Ohlandt G and
Hogan EL: Treatment of spinal cord impact injury in the rat with
transforming growth factor-beta. J Neurol Sci. 200:33–41.
2002.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Zhou W, Yuan T, Gao Y, Yin P, Liu W, Pan
C, Liu Y and Yu X: IL-1β-induces NF-κB and upregulates microRNA-372
to inhibit spinal cord injury recovery. J Neurophysiol.
117:2282–2291. 2017.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Barros AGC, Cristante AF, Santos GBD,
Natalino RJM, Ferreira RJR and Barros-Filho TEP: Evaluation of the
effects of erythropoietin and interleukin-6 in rats submitted to
acute spinal cord injury. Clinics (Sao Paulo).
74(e674)2019.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Gensel JC and Zhang B: Macrophage
activation and its role in repair and pathology after spinal cord
injury. Brain Res. 1619:1–11. 2015.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Ding J, Karp JE and Emadi A: Elevated
lactate dehydrogenase (LDH) can be a marker of immune suppression
in cancer: Interplay between hematologic and solid neoplastic
clones and their microenvironments. Cancer Biomark. 19:353–363.
2017.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Lv R, Du L, Zhang L and Zhang Z: Polydatin
attenuates spinal cord injury in rats by inhibiting oxidative
stress and microglia apoptosis via Nrf2/HO-1 pathway. Life Sci.
217:119–127. 2019.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Crowe MJ, Bresnahan JC, Shuman SL, Masters
JN and Beattie MS: Apoptosis and delayed degeneration after spinal
cord injury in rats and monkeys. Nat Med. 3:73–76. 1997.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Sekhon LH and Fehlings MG: Epidemiology,
demographics, and pathophysiology of acute spinal cord injury.
Spine (Phila Pa 1976). 26 (24 Suppl):S2–S12. 2001.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Gashmardi N, Hosseini SE, Mehrabani D,
Edalatmanesh MA and Khodabandeh Z: Impacts of bone marrow stem
cells on caspase-3 levels after spinal cord injury in mice. Iran J
Med Sci. 42:593–598. 2017.PubMed/NCBI
|
|
44
|
Thompson CD, Zurko JC, Hanna BF,
Hellenbrand DJ and Hanna A: The therapeutic role of interleukin-10
after spinal cord injury. J Neurotrauma. 30:1311–1324.
2013.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Takada Y, Singh S and Aggarwal BB:
Identification of a p65 peptide that selectively inhibits NF-kappa
B activation induced by various inflammatory stimuli and its role
in down-regulation of NF-kappaB-mediated gene expression and
up-regulation of apoptosis. J Biol Chem. 279:15096–15104.
2004.PubMed/NCBI View Article : Google Scholar
|
